2 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Birgitte Klug Albertsen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase GRASPA - Acute Lymphoblastic Leukemia | Phase 2 | Completed | Birgitte Klug Albertsen | 55 | 2017-08-23 | 2024-03-15 |
| Outcome Following Truncation of Asparaginase Relapse Leukemia | Completed | Birgitte Klug Albertsen | 1401 | 2008-07-01 | 2022-05-20 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)
eryaspase (1)
Denmark (2) · Estonia (1) · Finland (1) · Lithuania (1) · Norway (1) · Sweden (1)
Brigitte Klug Albertsen, MD, PhD (1)
2016 (1)